STOCKS | Boston Scientific Shares Drop 3.9% Pre-Market Following Full-Year Outlook Revision

Boston Scientific's stock experienced a 3.9% decline in pre-market trading after the company revised its full-year performance expectations. According to Jin10, the medical device manufacturer adjusted its forecast, impacting investor sentiment and leading to the drop in share price. The revision reflects changes in market conditions and company strategy, prompting investors to reassess their positions. Boston Scientific's adjustment highlights the challenges faced by companies in maintaining growth projections amidst evolving industry dynamics.